Wildebeest or malaria parasite -- same rules determine number of offspringJanuary 15, 2008Research has implications for treating many human and animal infections, including malaria and viruses Whether you are dealing with the number of wildebeest on the Serengeti or the number of malaria parasites in the human body, new research shows the same ecological framework determines breeding numbers and population size. New research published today (15 January) in Proceedings of the National Academy of Sciences by a Biotechnology and Biological Sciences Research Council (BBSRC) Fellow shows that the same community ecology principles that determine how different animal species on the savannah affect each other's population sizes through competition for food and hunting by predators also affect parasite species interacting within the microcosm of a single host. The research has important implications for treating many human and animal infections, including malaria and viruses. These infections rarely occur singularly and the research at the University of Edinburgh suggests that a range of drugs used to treat infection by parasitic worms may alter the effectiveness of anti-malarial and anti-viral treatments by affecting the level of competition among parasite species. The research, conducted by Dr Andrea Graham, a BBSRC David Phillips Fellow at the University of Edinburgh, examined data from a large number of animal studies of coinfection. A microparasite infection such as malaria often occurs in people already suffering from other parasites, such as worms. The research shows that these multiple infections affect each other by competing for host nutrients or by generating an impaired immune system response. The effect is the same as if a large herd of wildebeest started to eat all the available food in an area of the Serengeti. Analogously, the study found that if a host was suffering from a worm infection that caused a reduction in a nutrient needed by another parasite in the body at the same time, the second parasite would be reduced in number. Conversely, if a worm infection suppressed the immune response, other parasites would explode in numbers, just as zebras would rapidly breed in the absence of lions. Dr Graham said: "People and animals do not normally suffer just one parasite infection at a time. By applying the same ideas used in studies of big ecosystems to parasites I have been able to show that we need ecological thinking in order to understand and thus control multiple infections. This approach will help us to most effectively treat diseases such as malaria in a world that's full of co-infected hosts. "Researchers have mostly studied and treated viral and bacterial infections in isolation. This is because multiple-species infections were previously thought to be far too complex to be understood. Now I've shown that we need to think like ecologists to make the problem more controllable." Professor Nigel Brown, BBSRC Directory of Science and Technology, said: "This research focuses on understanding the fundamental biology of parasite infections but has huge practical implications. Ecological principles are here shown to have huge potential in understanding and treating parasitic disease, and shows the importance of interdisciplinary thinking in science and medicine." Biotechnology and Biological Sciences Research Council |
|||||||||||||||||||||
| Related Malaria Current Events and Malaria News Articles Measuring and modeling blood flow in malaria When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells. On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. Small nanoparticles bring big improvement to medical imaging If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging. Prioritizing low-cost, simple health measures would save 2.5 million child lives a year Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes. Drug industry, nonprofits join forces to fight world's neglected diseases Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. DNA barcodes: Creative new uses span health, fraud, smuggling, history, more The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others. PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||